Real world embedding
close
프로필 배경
프로필 로고

Real world embedding

  • 분류 전체보기 (422)
    • devOps (5)
    • Pharmacology (411)
      • News (8)
      • BS (402)
  • 홈
  • BS
  • devOps

ProMIS Completes Continuance to Ontario

ProMIS Neurosciences, Inc. has successfully completed its transition from the Canada Business Corporations Act to the Business Corporations Act in Ontario. This shift, approved by shareholders at the Annual Meeting of Shareholders, is expected to improve internal management functions while maintaining operations in Toronto and British Columbia. Led by Chief Scientific Officer Dr. Neil Cashman, P..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 16.
  • textsms

CurvaFix Closes $39 Million Series C Financing Round Led by MVM Partners and Announces CEO Transition

CurvaFix, Inc., a company specializing in the development of medical devices for repairing fractures in curved bones, has successfully concluded a series C financing round, raising an impressive $39 million. Leading the funding round is MVM Partners, a renowned investment firm. In addition to this exciting news, CurvaFix also announced a change in leadership, with Mark Foster taking on the role ..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 16.
  • textsms

Jenkins로 CI/CD 구축하기: 우분투 환경에서 자동화된 빌드 및 배포

1. CI/CD CI 는 개발자들의 코드 변경 사항을 자동으로 통합하여 빌드하고 테스트하는 프로세스입니다. CD 는 빌드 및 테스트가 완료된 코드를 자동으로 운영 서버에 배포하는 과정을 말합니다. 이를 통해 품질 향상과 개발 생산성의 향상을 기대해 볼수 있습니다. 2. Jenkins 소개와 기본 개념 Jenkins 는 오픈소스 자동화 서버로, CI/CD 파이프라인을 구축하기 위해 널리 사용됩니다. 자바로 작성되어있으며, 다양한 플러그인을 통해 기능 확장에 용이합니다. 유연하고 사용이 간단하여 개발자들에게 널리 알려져 있습니다. 3. Jenkins 소개와 기본 개념 Jenkins를 활용하여 자동으로 배포하는 과정은 CI/CD 파이프라인에 해당되는 단계로, 개발된 소프트웨어를 운영환경에 신속하게 배포하는 핵..

  • format_list_bulleted devOps
  • · 2023. 7. 16.
  • textsms

Mercury Bio and Himed Partner to Develop Novel Osteogenic Material for Orthopedic Applications

Mercury Bio, a biotech company based in Santa Fe, NM, has teamed up with Himed, a producer of bioceramics and biocompatible surface treatments for medical and dental implants. Together, they are working on developing an innovative osteogenic material specifically designed for orthopedic applications. The goal of this collaboration is to create a one-of-a-kind material that can be utilized in bon..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 14.
  • textsms

Grifols Meets Enrollment Target in Phase 3 Study of Two Dose Regimens of Prolastin®-C in Patients with Emphysema Due to Alpha-1-Antitrypsin Deficiency

Grifols Successfully Enrolls Targeted Number of Patients in Phase 3 Study of Prolastin®-C for Emphysema Due to Alpha-1-Antitrypsin Deficiency Grifols, a global leader in plasma-derived medicines, has achieved its enrollment goal of 339 patients for the SPARTA clinical trial. This groundbreaking study aims to assess the effectiveness and safety of two different weekly doses of Grifols' Prolastin®..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 14.
  • textsms

Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis

Incannex Healthcare Limited has received approval from the Bellberry Human Research Ethics Committee (HREC) for its Phase 2 clinical trial. The trial aims to evaluate the effectiveness of IHL-675A, a unique anti-inflammatory combination drug product, in patients suffering from rheumatoid arthritis (RA). This pivotal trial comes after a successful Phase 1 study where IHL-675A demonstrated excelle..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 14.
  • textsms

Health Canada Approves Lynparza in Combination with Abiraterone and Prednisone or Prednisolone for Patients with BRCA Mutated Metastatic Castration-Resistant Prostate Cancer

Health Canada has granted conditional approval for the use of Lynparza in combination with abiraterone and prednisone or prednisolone to treat patients with BRCA mutated metastatic castration-resistant prostate cancer. This exciting development is based on the promising results from the Phase 3 PROpel trial, which demonstrated that patients receiving Lynparza/abiraterone experienced improved rad..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 14.
  • textsms

electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC

electroCore, Inc. has recently announced an exclusive distribution agreement with Reliefband Technologies, LLC. This agreement allows electroCore to distribute Reliefband's ReletexTM device within the Department of Veterans Affairs and other eligible entities. The Reletex device is a non-invasive neuromodulation device that has been cleared by the FDA for the treatment of nausea and vomiting. As..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 14.
  • textsms

Inogen Expands Its Respiratory Product Portfolio with Acquisition of Physio-Assist

Inogen Expands Its Respiratory Product Portfolio with Acquisition of Physio-Assist &nbsp In a move to become a global leader in respiratory care, Inogen, Inc. has announced its acquisition of Physio-Assist SAS. This strategic acquisition allows Inogen to broaden its product offerings and tap into the growing and underserved airway clearance market. &nbsp Furthermore, Inogen has provided a prelim..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 14.
  • textsms

Simulations Plus Releases ADMET Predictor® 11

Simulations Plus Unveils ADMET Predictor® 11, Revolutionizing Drug Modeling and Simulation &nbsp In a groundbreaking move, Simulations Plus, Inc. (Nasdaq: SLP), a renowned leader in the field of modeling and simulation solutions for the pharmaceutical and biotechnology industries, has officially launched ADMET Predictor® 11. This cutting-edge version of their flagship machine learning modeling p..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 14.
  • textsms
  • navigate_before
  • 1
  • ···
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • ···
  • 43
  • navigate_next
공지사항
  • 데이터 요청 관련 문의
전체 카테고리
  • 분류 전체보기 (422)
    • devOps (5)
    • Pharmacology (411)
      • News (8)
      • BS (402)
최근 글
인기 글
최근 댓글
태그
  • #Study
  • #Phase 3
  • #FDA approval
  • #N/A
  • #Safety
  • #cancer
  • #Clinical Trial
  • #fda
  • #astrazeneca
  • #Trial
전체 방문자
오늘
어제
전체
Copyright © 쭈미로운 생활 All rights reserved.
Designed by JJuum

티스토리툴바